Sabera Hyderally, Purdie Pascoe’s Head of US MedTech, recently facilitated an engaging, honest, and thought-provoking conversation with experts from across the MedTech and Diagnostics industry. The discussion explored how MedTech differs from other sectors, particularly pharmaceuticals, and what these differences mean for how we approach market research, innovation, and patient engagement. 

With over 50 of us now based across the UK, US, and Europe, this year’s meeting was a true celebration of our growth, our people, and our commitment to MedTech. Fittingly, our theme this year was bold and simple: MedTech, as it’s not just one of our sectors - it’s our sole focus.

While quantitative data can reveal what is happening, qualitative insights uncover the why; shedding light on patient experiences, clinician workflows, and unmet needs that numbers alone can't capture. By diving deep into real-world perspectives, MedTech companies can design more intuitive devices, craft compelling value propositions, and navigate complex regulatory and reimbursement landscapes with greater confidence.

As we navigate through the busy conference season, the industry is buzzing with innovation, networking, and knowledge sharing. Conferences are pivotal events that drive advancements, offering a unique platform for professionals to stay ahead of the curve. However, the true value of these events lies in the insights they generate.

Our client, a market-leading provider of vascular surgery products for aortic and peripheral vascular disease, wanted to understand how they could better service interventional cardiologists (ICs) and their patients by understanding ICs’ preferences, perceptions, and influences and priorities.

As the ctDNA cancer monitoring market becomes increasingly competitive, established panels continue to maintain their foothold amidst a surge of new entrants. Purdie Pascoe is conducting an ongoing syndicated study exploring the US ctDNA Cancer Monitoring Landscape. Waves 1 through 3 are available for immediate purchase, with Wave 4 launching soon.

In the fast-evolving world of medical technology, innovation alone isn’t enough. A brilliant device or digital therapeutic can fail if it doesn’t align with the needs of end users, clinical workflows, or regulatory pathways. That’s where market research steps in, not as a luxury, but as a strategic necessity.

Partnering with an external team that understands and supports every stage of the MedTech journey can be transformative. In this conversation, leading experts share how Purdie Pascoe’s integrated expertise in Primary Market Research and Post Market Surveys is the true golden ticket to a seamless, compliant, and impactful approach for success in your MedTech journey.

Find out how we provided our client with a clear and effective path forward to help launch their pre-filled syringes for subcutaneous immunoglobulin therapy, and how best to position themselves for widespread adoption.

In a world where many agencies claim to serve MedTech, very few are true specialists. MedTech isn’t just one of our sectors - it’s our sole focus. That’s what sets us apart. We’re proudly returning to our roots and doubling down on what we do best; helping companies like yours make smarter, faster, and more confident decisions.

Stephen Potts, Director at Purdie Pascoe, was recently interviewed by Rohit Sahgal, Chief Editor and AI Strategist at TVP Singapore, for the first episode of the 6th season of the Voices Project Asia Podcast. They delve into a range of topics such the importance of relationships in Asia, innovation, finding a ‘killer insight’, navigating the era of ‘info-besity’, rare diseases and the growing role of AI in healthcare.

Paolo Gambetti, Head of Innovation, recently attended the IIEX Europe Innovation conference in Amsterdam. In this blog, he summarises his key takeaways from AI-moderated interviews, smarter visual and behavioural testing, data quality and efficiency and thinking outside the (AI) box.

Primary market research for precision medicine and diagnostics is complex, yet essential. The landscape is shaped by rapid advancements in genomic and proteomic sciences, the increased complexity of treatment algorithm and the need for early detection and personalised treatment plans. These factors create a dynamic environment where understanding market trends, customer needs and the competitive landscape is crucial for success.

When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimise the true value of the voice of your customer? In this article, Sabera Hyderally and Hazel Haskayne showcase the true value of the Delphi Method and how it can be used in market research as a powerful tool for reaching consensus.

We are delighted to be attending and presenting a paper at the EphMRA Conference from 24-26 June in London. Directors Stephen Potts and Hazel Haskayne will be representing Purdie Pascoe at the event and are excited to meet fellow industry experts and delve into the latest intelligent thinking which is truly making a difference in healthcare market research worldwide.

We are delighted to have been shortlisted for this year’s BHBIA BOBI awards, celebrating the best of business intelligence in UK healthcare. Purdie Pascoe’s submission, in collaboration with Chiesi, 'Navigating the Storm: Improving Referral Behaviours to Accelerate Fabry Disease Care' has been shortlisted in the best customer insight category.

The research world is buzzing with AI. Everywhere you look, new tools promise faster, deeper, cheaper insights. But if you peel back the marketing gloss, a more nuanced question emerges: Where does AI genuinely help—and where does it fall short?

As Head of Innovation at Purdie Pascoe, Paolo Gambetti offers his perspective about innovation in healthcare market research. He addresses a range of important points such as key drivers of innovation, how his dedicated team identifies emerging trends and technologies and the impact of AI and machine learning in the space.

When visiting a sensitive, emotive topic as a means to creating or refining a communications strategy, how can you optimize the true value of the voice of your customer? Watch this webcast in which Purdie Pascoe’s expert presenters, Head of MedTech, Sabera Hyderally and Director, Hazel Haskayne, show the true value of the Delphi Method.

Find out how we used a staged qualitative approach to help our client understand the landscape of digital solutions in GI endotherapy with a focus on AI, data management (clinical and non-clinical), workflow, and supply management.